BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 10653863)

  • 21. [Neuroblastoma in children under than 1 year of age].
    Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
    An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
    Sibley GS; Mundt AJ; Goldman S; Nachman J; Reft C; Weichselbaum RR; Hallahan DE; Johnson L
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1127-35. PubMed ID: 7607934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
    Katzenstein HM; Bowman LC; Brodeur GM; Thorner PS; Joshi VV; Smith EI; Look AT; Rowe ST; Nash MB; Holbrook T; Alvarado C; Rao PV; Castleberry RP; Cohn SL
    J Clin Oncol; 1998 Jun; 16(6):2007-17. PubMed ID: 9626197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
    Perez CA; Matthay KK; Atkinson JB; Seeger RC; Shimada H; Haase GM; Stram DO; Gerbing RB; Lukens JN
    J Clin Oncol; 2000 Jan; 18(1):18-26. PubMed ID: 10623689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
    Chan EL; Harris RE; Emery KH; Gelfand MJ; Collins MH; Gruppo RA
    Pediatr Blood Cancer; 2007 Apr; 48(4):479-82. PubMed ID: 16333837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
    Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
    J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
    Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
    J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia.
    Evans AE; Chatten J; D'Angio GJ; Gerson JM; Robinson J; Schnaufer L
    Cancer; 1980 Mar; 45(5):833-9. PubMed ID: 7260834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents.
    West DC; Shamberger RC; Macklis RM; Kozakewich HP; Wayne AS; Kreissman SG; Korf BR; Lavally B; Grier HE
    J Clin Oncol; 1993 Jan; 11(1):84-90. PubMed ID: 8418247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
    De Bernardi B; Gerrard M; Boni L; Rubie H; Cañete A; Di Cataldo A; Castel V; Forjaz de Lacerda A; Ladenstein R; Ruud E; Brichard B; Couturier J; Ellershaw C; Munzer C; Bruzzi P; Michon J; Pearson AD
    J Clin Oncol; 2009 Mar; 27(7):1034-40. PubMed ID: 19171711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
    Meany HJ; London WB; Ambros PF; Matthay KK; Monclair T; Simon T; Garaventa A; Berthold F; Nakagawara A; Cohn SL; Pearson AD; Park JR
    Pediatr Blood Cancer; 2014 Nov; 61(11):1932-9. PubMed ID: 25044743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
    DuBois SG; Kalika Y; Lukens JN; Brodeur GM; Seeger RC; Atkinson JB; Haase GM; Black CT; Perez C; Shimada H; Gerbing R; Stram DO; Matthay KK
    J Pediatr Hematol Oncol; 1999; 21(3):181-9. PubMed ID: 10363850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
    Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H
    Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
    Twist CJ; Schmidt ML; Naranjo A; London WB; Tenney SC; Marachelian A; Shimada H; Collins MH; Esiashvili N; Adkins ES; Mattei P; Handler M; Katzenstein H; Attiyeh E; Hogarty MD; Gastier-Foster J; Wagner E; Matthay KK; Park JR; Maris JM; Cohn SL
    J Clin Oncol; 2019 Dec; 37(34):3243-3255. PubMed ID: 31386611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
    Iehara T; Hiyama E; Tajiri T; Yoneda A; Hamazaki M; Fukuzawa M; Hosoi H; Sugimoto T; Sawada T
    Eur J Cancer; 2012 Jul; 48(11):1707-12. PubMed ID: 22305511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage IV neuroblastoma in infants. Long-term survival.
    Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE
    Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma.
    Ng SM; Abdullah WA; Lin HP; Chan LL
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):149-53. PubMed ID: 10695803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
    Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
    [No Abstract]   [Full Text] [Related]  

  • 40. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.
    Montalto S; Sertorio F; Podda M; Sorrentino S; Di Cataldo A; Provenzi M; Nonnis A; D'Ippolito C; Corrias MV; De Bernardi B
    Pediatr Hematol Oncol; 2022 Aug; 39(5):441-452. PubMed ID: 35139733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.